Presima Securities ULC Grows Stock Holdings in Healthpeak Properties, Inc. $DOC

Key Points

• Presima Securities ULC increased its stake in Healthpeak Properties, Inc. by 6.0%, now holding 737,146 shares valued at approximately $14.9 million.
• Equities research analysts have shown a bearish trend, with several firms lowering their ratings and price targets, including Scotiabank cutting its target from $21.00 to $19.00.
• Healthpeak Properties recently declared a monthly dividend of $0.1017, representing a dividend yield of 6.6% despite a high payout ratio of 508.33%.

Presima Securities ULC boosted its stake in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 6.0% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 737,146 shares of the real estate investment trust's stock after buying an additional 41,930 shares during the period. Healthpeak Properties accounts for approximately 3.3% of Presima Securities ULC's portfolio, making the stock its 13th largest position. Presima Securities ULC owned 0.11% of Healthpeak Properties worth $14,905,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Invesco Ltd. grew its stake in shares of Healthpeak Properties by 20.7% in the first quarter. Invesco Ltd. now owns 23,111,320 shares of the real estate investment trust's stock worth $467,311,000 after acquiring an additional 3,967,830 shares during the last quarter. Fuller & Thaler Asset Management Inc. increased its stake in Healthpeak Properties by 6.5% in the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 18,397,841 shares of the real estate investment trust's stock worth $372,004,000 after buying an additional 1,129,924 shares in the last quarter. Centersquare Investment Management LLC increased its stake in Healthpeak Properties by 18.5% in the 1st quarter. Centersquare Investment Management LLC now owns 13,285,932 shares of the real estate investment trust's stock worth $268,642,000 after buying an additional 2,070,416 shares in the last quarter. Dimensional Fund Advisors LP grew its position in shares of Healthpeak Properties by 0.7% during the first quarter. Dimensional Fund Advisors LP now owns 10,392,052 shares of the real estate investment trust's stock valued at $210,126,000 after purchasing an additional 76,978 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. grew its position in shares of Healthpeak Properties by 0.8% during the first quarter. Charles Schwab Investment Management Inc. now owns 10,238,001 shares of the real estate investment trust's stock valued at $207,012,000 after purchasing an additional 84,551 shares in the last quarter. 93.57% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Healthpeak Properties

In related news, CEO Scott M. Brinker bought 2,930 shares of the company's stock in a transaction on Thursday, July 31st. The stock was bought at an average cost of $17.06 per share, with a total value of $49,985.80. Following the completion of the acquisition, the chief executive officer owned 210,416 shares in the company, valued at approximately $3,589,696.96. This represents a 1.41% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders have bought 8,783 shares of company stock valued at $150,129 over the last three months. Company insiders own 0.23% of the company's stock.

Healthpeak Properties Stock Up 0.0%

Shares of DOC traded up $0.01 during mid-day trading on Friday, reaching $18.15. The company's stock had a trading volume of 2,058,462 shares, compared to its average volume of 6,071,684. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.28 and a quick ratio of 1.28. Healthpeak Properties, Inc. has a 12-month low of $16.63 and a 12-month high of $23.26. The stock has a market cap of $12.61 billion, a PE ratio of 75.65, a price-to-earnings-growth ratio of 2.31 and a beta of 1.07. The company's 50 day moving average is $17.76 and its 200 day moving average is $18.21.

Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 EPS for the quarter, meeting analysts' consensus estimates of $0.46. The business had revenue of $694.35 million for the quarter, compared to analysts' expectations of $697.14 million. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. The company's quarterly revenue was down .2% on a year-over-year basis. During the same period in the previous year, the company posted $0.45 EPS. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. Equities analysts anticipate that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The business also recently announced a monthly dividend, which was paid on Friday, August 29th. Shareholders of record on Monday, August 18th were issued a $0.1017 dividend. The ex-dividend date of this dividend was Monday, August 18th. This represents a c) dividend on an annualized basis and a yield of 6.7%. Healthpeak Properties's dividend payout ratio (DPR) is 508.33%.

Analyst Upgrades and Downgrades

Several analysts have issued reports on DOC shares. Morgan Stanley decreased their price objective on shares of Healthpeak Properties from $22.00 to $21.00 and set an "overweight" rating for the company in a research note on Friday, August 22nd. Robert W. Baird set a $21.00 target price on Healthpeak Properties and gave the company an "outperform" rating in a research report on Wednesday, July 30th. Wall Street Zen downgraded Healthpeak Properties from a "hold" rating to a "sell" rating in a research report on Monday, July 7th. Wells Fargo & Company lowered their price target on shares of Healthpeak Properties from $20.00 to $18.00 and set an "equal weight" rating on the stock in a report on Wednesday, August 27th. Finally, Deutsche Bank Aktiengesellschaft reissued a "hold" rating and set a $18.00 target price (down from $28.00) on shares of Healthpeak Properties in a research note on Wednesday, August 20th. Seven equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to MarketBeat, Healthpeak Properties presently has an average rating of "Moderate Buy" and a consensus target price of $21.50.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.